Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Magellan Health, Inc. operates primarily in the healthcare plans sector, providing managed care services, pharmacy benefit management, and behavioral health services across the United States. The company has a unique competitive position due to its integrated approach to healthcare management, focusing on specialized services in behavioral health and pharmacy management, which are increasingly in demand.
Magellan Health generates revenue primarily through capitation and fee-for-service models in managed care, alongside rebates and administrative fees in pharmacy benefit management. Its competitive advantages include a strong network of healthcare providers and proprietary data analytics capabilities that enhance patient outcomes and cost efficiencies.
Changes in Medicaid and Medicare reimbursement rates
Growth in behavioral health service demand
Pharmacy benefit management contract renewals
Regulatory changes impacting healthcare plans
Regulatory changes that could impact reimbursement rates and operational flexibility
Technological disruption in healthcare delivery models
Intensifying competition from larger healthcare plans and emerging telehealth providers
Potential loss of key contracts in pharmacy benefit management
Low net margin of 0.1% indicating vulnerability to operational inefficiencies
Increasing operational costs due to regulatory compliance
moderate - The healthcare sector is somewhat insulated from economic downturns, but changes in consumer spending and government funding can impact revenues.
Higher interest rates can increase financing costs for the company, potentially impacting its ability to invest in growth initiatives and affecting valuation multiples due to higher discount rates.
minimal - The company has a manageable debt-to-equity ratio of 0.34, indicating limited reliance on credit markets.
value - Given the current low valuation metrics and potential for recovery in operational performance.
moderate - The stock has shown stability in returns, but the significant revenue decline indicates potential for volatility.
